Important Dates: Date of Release: March 24, 2025Term of Approval/Date of Expiration: March 24, 2026 Learner Objective(s): Upon completion of this activity, you should be able to:
Analyze the synergistic effects between devices and drugs in HF treatment.
Acknowledgement Educational grant support provided by: CVRx, Inc.
Faculty:Lee R. Goldberg, MD, MPH, FACC Professor of Medicine, Vice Chair of MedicineUniversity of Pennsylvania Philadelphia, Pennsylvania Disclosures Consultant Fees/Honoraria: Respircardia/Zoll; Research/Research Grants: Respircardia/Zoll; Stock: Viscardia